Lumos Pharma Inc. (LUMO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.00

-100.00%

After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08
Revenue	2.05M	1.52M	230.00K	168.00K	936.00K	1.21M	390.00K	3.53M	36.14M	165.95M	1.09M	1.69M	1.87M	2.08M	934.00K	633.00K
Cost of Revenue	-	49.00K	-	-	37.00K	-11.27M	1.41M	-	-32.36M	-6.64M	-	-	-	-	-	-
Gross Profit	2.05M	1.47M	230.00K	168.00K	899.00K	12.47M	-1.02M	3.53M	68.50M	172.59M	1.09M	1.69M	1.87M	2.08M	934.00K	633.00K
Operating Income	-36.61M	-32.04M	-31.35M	-26.30M	-45.13M	-62.44M	-72.88M	-90.76M	-33.60M	117.57M	-31.14M	-23.26M	-18.06M	-16.66M	-9.82M	-9.41M
Interest Income	1.87M	874.00K	12.00K	200.00K	2.23M	2.03M	616.00K	237.00K	78.00K	86.00K	12.00K	14.00K	11.00K	75.00K	132.00K	213.00K
Pretax Income	-34.06M	-31.07M	-31.07M	-19.64M	-42.98M	-60.56M	-72.51M	-90.51M	-33.64M	117.63M	-31.05M	-23.32M	-18.09M	-16.59M	-9.80M	-9.37M
Net Income	-34.03M	-31.06M	-30.43M	-5.66M	-42.99M	-53.59M	-71.95M	-85.16M	-40.38M	102.86M	-31.18M	-23.32M	-18.09M	-16.21M	-9.44M	-9.16M
Selling & General & Admin	16.57M	15.71M	15.33M	17.27M	23.86M	29.22M	31.73M	33.23M	30.69M	19.33M	9.52M	7.11M	5.68M	6.07M	5.19M	4.60M
Research & Development	22.10M	17.86M	16.25M	9.21M	22.20M	45.69M	69.87M	93.30M	71.41M	35.69M	22.71M	17.84M	14.26M	12.67M	5.56M	5.45M
Other Expenses	-	91.00K	269.00K	6.47M	-19.00K	-102.00K	371.00K	247.00K	-41.00K	60.00K	91.00K	-62.00K	-	-	-	-
Operating Expenses	38.66M	33.56M	31.58M	26.47M	46.07M	63.64M	73.27M	94.28M	69.75M	48.38M	31.14M	23.26M	19.93M	18.74M	10.75M	10.05M
Interest Expense	-	874.00K	-	-	50.00K	52.00K	119.00K	22.00K	105.00K	26.00K	33.00K	38.00K	42.00K	47.00K	9.00K	2.00K
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	38.66M	33.56M	31.58M	26.47M	46.07M	63.64M	73.27M	94.28M	69.75M	48.38M	31.14M	23.26M	19.93M	18.74M	10.75M	10.05M
Income Tax	-29.00K	-13.00K	-636.00K	-13.97M	12.00K	-6.97M	-559.00K	-5.36M	6.74M	14.78M	130.00K	-788.00K	41.00K	-448.00K	-375.00K	-253.00K
Shares Outstanding (Basic)	8.15M	8.37M	8.33M	6.78M	144.71K	4.13M	3.48M	3.22M	3.18M	3.09M	2.81M	2.31M	673.84K	1.60M	1.60M	1.60M
Shares Outstanding (Diluted)	8.15M	8.37M	8.33M	6.78M	144.71K	4.13M	3.48M	3.22M	3.18M	3.45M	2.81M	2.31M	673.84K	1.60M	1.60M	1.60M
EPS (Basic)	-4.18	-3.71	-3.65	-0.84	-297.07	-12.97	-20.69	-26.45	-12.71	31.05	-11.1	-10.1	-26.84	-10.15	-5.91	-5.74
EPS (Diluted)	-4.18	-3.71	-3.65	-0.84	-297.07	-12.97	-20.69	-26.45	-12.71	27.81	-11.1	-10.1	-26.84	-10.15	-5.91	-5.74
EBITDA	-36.57M	-31.99M	-31.13M	-25.72M	-45.13M	-59.37M	-70.98M	-88.41M	-31.95M	118.76M	-30.13M	-22.50M	-17.52M	-16.08M	-9.89M	-9.12M
Depreciation & Amortization	44.00K	49.00K	273.00K	584.00K	37.00K	1.15M	1.41M	2.08M	1.59M	1.10M	891.00K	788.00K	687.00K	655.00K	303.00K	294.00K